United States & Novartis
14 shared events · Importance 4 · Last updated Aug 14, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
International
United States: The United States is receiving significant investment from Swiss companies, which will boost its economy and create jobs, though it also imposed new tariffs related to forced labor.
Novartis: Novartis is a key investor, announcing two U.S. projects: a biomedical research center in San Diego and a cancer-drug production facility in Texas.
Jun 07, 2026 · 7 articles
Business
United States: The US is part of North America, which held the largest market share in 2025, supported by strong regulatory frameworks and advanced manufacturing.
Novartis: Novartis is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Regulatory
United States: The United States is noted as a jurisdiction where Novartis lost a bid to block a generic version of Sacubitril/valsartan, representing a contrasting legal outcome.
Novartis: Novartis is the patent holder and beneficiary of the court ruling, which protects its blockbuster drug Sacubitril/valsartan from generic competition in the UK, supporting its revenue and market position.
Aug 13, 2026 · 6 articles
Regulatory
United States: The U.S. FDA granted approval, impacting the domestic IgAN patient population of about 160,000.
Novartis: Novartis' Fabhalta and Vanrafia are among the competitors to TRUTAKNA in IgAN.
Jul 07, 2026 · 6 articles
Business
United States: The US is a key market for PentixaFor, with an expanded patient pool due to new screening guidelines.
Novartis: Novartis reported strong Pluvicto sales growth, indicating a booming radiopharma market that could benefit PentixaFor's launch.
Jul 15, 2026 · 10 articles
Domestic
United States: Prospects of a peace deal between Iran>>> and the United States>>> influenced investor sentiment, contributing to the positive mood in the Switzerland>>> market.
Novartis: Novartis>>> shed 0.3%-0.7% in one session but moved up by 1.85% in another, showing mixed performance in the Switzerland>>> market.
May 21, 2026 · 8 articles
Business
United States: The United States is the regulatory and market jurisdiction for the IPO, with the SEC and Nasdaq based there.
Novartis: Novartis' Leqvio is another competitor in the PCSK9 inhibitor market. Scribe's progress may affect Novartis's competitive position.
Jul 06, 2026 · 25 articles
Business
United States: The United States is the primary market for Lantheus' products and the regulatory jurisdiction for the deal, with potential antitrust review.
Novartis: Novartis is mentioned as the maker of Pluvicto, a competitor to a Lantheus-Eli Lilly therapeutic that was abandoned.
Aug 03, 2026 · 7 articles
Business
United States: Country where Palsonify is approved and where most patients reside.
Novartis: Competitor in acromegaly market.
Jul 06, 2026 · 34 articles
Regulatory
Novartis: Novartis is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
Business
Novartis: Novartis settled a lawsuit with the estate of Henrietta Lacks over the unauthorized use of her cells, which were used to develop various medical advancements. This settlement resolves a significant legal and ethical challenge for Novartis.
Feb 26, 2026 · 7 articles
International
Novartis: Novartis employed Jason Thomas, a pharmaceutical researcher who was found dead after disappearing, adding a pharmaceutical link to the broader pattern of mysterious deaths.
Apr 11, 2026 · 6 articles
Business
Novartis: Novartis announced the expansion of its community health programs to address gaps in heart disease and cancer care globally, which could positively impact its public image and long-term market position.
Apr 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Novartis interact across events, view sentiment trends, and discover connected entities.
Open Dashboard